Calcium Trisodium Pentetate (Ca-DTPA) (W6369-22-A048/A)
Process Number PW-21-00977237
Dates:
2021-12-03 00:00:00
Amendment date:None
Date closing:2022/01/14 14:00 Eastern Standard Time (EST)
Details:
Ontario
Department of National Defence
Department of National Defence
National Capital Region
Open
PW-21-00977237
W6369-22-A048/A
Description:
Department of National Defence (DND), has a requirement for Calcium trisodium pentetate (Ca-DTPA) for the treatment of Canadian Armed Forces (CAF) members who may have been exposed to radiological warfare agents. The period of the Contract is from date of Contract to 31 March 2025 inclusive. Initial Requirement: The Contractor must supply 250 ampoules no later than 31 March 2022. Optional Requirements: a. Optional Requirement 1 (01 April 2022-31 March 2023): If exercised, the Contractor must supply up to 250 ampoules no later than 31 March 2023. b. Optional Requirement 2 (01 April 2023-31 March 2024): If exercised, the Contractor must supply up to 250 ampoules no later than 31 March 2024. c. Optional Requirement 3 (01 April 2024-31 March 2025): If exercised, the Contractor must supply up to 250 ampoules no later than 31 March 2025.
Contact information:
Payeur, Marie-diane
Contact email:Marie-Diane.Payeur@forces.gc.ca
Contact phone:105 Hotel de Ville Gatineau QC K1O 0K2 CA
Contact Fax:Solicitation Documents:
| File | Amendment Number | Language | Date added |
|---|---|---|---|
| w6369-22-a048_ca-dtpa-rfp_en.pdf | 000 | English | 2021-12-03 |
| w6369-22-a048_rfp_fr.pdf | 000 | French | 2021-12-03 |